The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc

FEBS Letters

Volumn 580, Issue 2, 2006, Pages 431-436

  Kalra, Neetu ^a   Kumar, Vijay ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

c Myc; F box protein; Skp1 Cullin1 F box protein complex; Skp2; Ubiquitination; X protein of hepatitis B virus

Indexed keywords

F BOX PROTEIN; HEPATITIS B VIRUS X PROTEIN; MYC PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2;

ARTICLE; CELL TRANSFORMATION; DEREGULATION; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; MITOGENESIS; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEGRADATION; UBIQUITINATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYSTEINE PROTEINASE INHIBITORS; HUMANS; LIVER NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANS-ACTIVATORS; UBIQUITINS;

HEPATITIS B VIRUS;

EID: 30644461154     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.12.034     Document Type: Article

References (30)

1. V. O'Brien Viruses and apoptosis J. Gen. Virol. 79 1998 1833 1845
2. C. Swanson, and N. Jones Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products Int. J. Exp. Pathol. 82 2001 3 13
3. T. Cardozo, and M. Pagano The SCF ubiquitin ligase: insights into a molecular machine Nat. Rev. Mol. Cell. Biol. 5 2004 739 751
4. M.H. Glickman, and A. Ciechanover The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction Physiol. Rev. 82 2002 373 428
5. M. Scheffner, J.M. Huibregtse, R.D. Vierstra, and P.M. Howley The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 Cell 75 1993 495 505
6. R.N. Harty, M.E. Brown, J.P. McGettigan, G. Wang, H.R. Jayakar, J.M. Huibregtse, M.A. Whitt, and M.J. Schnell Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction J. Virol. 75 2001 10623 10629
7. G. Winberg, L. Matskova, F. Chen, P. Plant, D. Rotin, G. Gish, R. Ingham, I. Ernberg, and T. Pawson Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases Mol. Cell. Biol. 20 2000 8526 8535
8. L. Coscoy, D.J. Sanchez, and D. Ganem A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition J. Cell Biol. 155 2001 1265 1273
9. S. Bour, C. Perrin, H. Akari, and K. Strebel The human immunodeficiency virus type I Vpu protein inhibits NF-κB activation by interfering with βTrCP-mediated degradation of IκB J. Biol. Chem. 276 2001 15920 15928
10. V. Kumar, and D.P. Sarkar Hepatitis B virus X protein (HBx): structure-function relationships and role in viral pathogenesis S.J. Triezenberg J. Kaufman M. Gossen Handbook of Experimental Pharmacology 2004 Springer-Verlag Germany 377 407
11. Z. Hu, Z. Zhang, E. Doo, O. Coux, A.I. Goldberg, and T.J. Liang Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex J. Virol. 73 1999 7231 7240
12. H. Sirma, R. Weil, O. Rosmorduc, S. Urban, A. Israel, D. Kremsdorf, and C. Brechot Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome Oncogene 16 1998 2051 2063
13. Z. Zhang, U. Protzer, Z. Hu, J. Jacob, and T.J. Liang Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBx-dependent manner J. Virol. 78 2004 4566 4572
14. C. Balsano, M.L. Avantaggiati, G. Natoli, E. De Marzio, E.H. Will, M. Perricaudet, and M. Levrero Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the c-myc protooncogene at the transcriptional level Biochem. Biphys. Res. Commun. 176 1991 985 992
15. R. Lakhtakia, V. Kumar, H. Reddi, M. Mathur, S. Dattagupta, and S.K. Panda Hepatocellular carcinoma in a hepatitis B 'X' transgenic mouse model: a sequential pathological evaluation J. Gastroenterol. Hepatol. 18 2003 80 91
16. O. Terradillos, O. Billet, C.A. Renard, R. Levy, T. Molina, P. Briand, and M.A. Buendia The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice Oncogene 14 1997 395 404
17. V. Kumar, N. Jayasuryan, and R. Kumar A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function Proc. Natl. Acad. Sci. USA 93 1996 5647 5652
18. N. Kalra, and V. Kumar c-Fos is a mediator of the c-myc-induced apoptotic signaling in serum-deprived hepatoma cells via the p38 mitogen-activated protein kinase pathway J. Biol. Chem. 279 2004 25313 25319
19. N. von der Lehr, S. Johansson, S. Wu, F. Bahram, A. Castell, C. Cetinkaya, P. Hydbring, I. Weidung, K. Nakayama, K.I. Nakayama, O. Soderberg, T.K. Kerppola, and L.G. Larsson The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription Mol. Cell 2003 1189 1200
20. S.Y. Kim, A. Herbst, K.A. Tworkowski, S.E. Salghetti, and W.P. Tansey Skp2 regulates Myc protein stability and activity Mol. Cell 11 2003 1177 1188
21. M. Welcker, A. Orian, J. Jin, J.A. Grim, J.W. Harper, R.N. Eisenman, and B.E. Clurman The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation Proc. Natl. Acad. Sci. USA 101 2004 9085 9090
22. M. Yada, S. Hatakeyama, T. Kamura, M. Nishiyama, R. Tsunematsu, H. Imaki, N. Ishida, F. Okumura, K. Nakayama, and K.I. Nakayama Phosphorylation-dependent degradation of c-Myc is mediated by the F box protein Fbw7 EMBO J. 23 2004 2116 2125
23. J.H. Kim, S. Kang, J. Kim, and B.Y. Ahn Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein J. Virol. 77 2003 7166 7173
24. L. Banks, D. Pim, and M. Thomas Viruses and the 26S proteasome: hacking into destruction Trends Biochem. Sci. 28 2003 452 459
25. J. Shackelford, and J.S. Pagano Tumor viruses and cell signaling pathways: deubiquitination versus ubiquitination Mol. Cell. Biol. 24 2004 5089 5093
26. R. Piva, J. Liu, R. Chiarle, A. Podda, M. Pagano, and G. Inghirami In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation Mol. Cell. Biol. 22 2002 8375 8387
27. M. Gstaiger, R. Jordan, M. Lim, C. Catzavelos, J. Mestan, J. Slingerland, and W. Krek Skp2 is oncogenic and overexpressed in human cancers Proc. Natl. Acad. Sci. USA 98 2001 5043 5048
28. Y.C. Kim, K.S. Song, G. Yoon, M.J. Nam, and W.S. Ryu Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis Oncogene 20 2001 16 23
29. R.J. Sheaff, J.D. Singer, J. Swanger, M. Smitherman, J.M. Roberts, and B.E. Clurman Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination Mol. Cell 5 2000 403 410
30. D.W. Felsher, and J.M. Bishop Transient excess of MYC activity can elicit genomic instability and tumorigenesis Proc. Natl. Acad. Sci. USA 96 1999 3940 3944